Suzhou Tianma Pharma Group

Suzhou Tianma Pharma Group is a comprehensive pharmaceutical enterprise based in Suzhou, China, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and finished dosages. The company is a global leader in peptide synthesis, offering a wide range of peptide APIs such as Eptifibatide, Teriparatide, and Bivalirudin through its subsidiary, Tianji Bio-pharmaceutical. In addition to its peptide portfolio, the group produces various small molecule APIs for cardiovascular, metabolic, and oncological indications. Suzhou Tianma operates multiple GMP-certified facilities and provides contract development and manufacturing (CDMO) services to international partners. Its business spans the entire value chain from fine chemicals and amino acid derivatives to advanced pharmaceutical products.